DAIC

APRIL 22, 2024

This is an innovative platform for measuring biomarkers,” stated Dr. Karlsberg. This study highlights the value of digital biomarkers that may enable instantaneous feedback for care providers in assessing the patient. Featured in an ACC.24

Technology 105

Technology Biomarkers Heart Attack Heart attacks 105

DAIC

MARCH 6, 2024

a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.

Heart Failure 128

Heart Failure Technology Biomarkers Hospital 128

Cardiometabolic Health Congress

JULY 25, 2024

A jam-packed, expertly curated agenda will highlight the latest and most impactful advancements in cardiorenal metabolic medicine and protocols for future-focused, whole-patient care.

Education 100

Education Innovation Risk Factors Obesity 100

DAIC

DECEMBER 22, 2023

“By pioneering a user-friendly device that enables frequent 12-lead ECGs over time and by coupling AI with our proprietary VECG technology that can go beyond a 12-lead ECG, HeartBeam is well-positioned to identify nuanced cardiac trends that could ultimately improve patient care.”

Technology 105

Technology Electrocardiogram Heart Rhythm Biomarkers 105

GEMMS

MAY 22, 2024

These advancements, alongside software enhancements, enable early detection of cardiac diseases, empowering healthcare providers to make evidence-based decisions and tailor appropriate patient care plans. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Cardiometabolic Health Congress

OCTOBER 25, 2024

Libby made a poignant observation, emphasizing that his LDL goal for patients is “ALARA: As Low As Reasonably Achieved.” Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I I am very inspired and rejuvenated at the 19th Annual CMHC.

CME 64

CME Innovation Education Atherosclerosis 64

DAIC

MAY 17, 2024

Philips’ study reveals that AI-powered ECG biomarker technology may help to identify patients with significant intermittent bradyarrhythmia, potentially improving timely diagnosis and management.

Heart Rhythm 52

Heart Rhythm Technology Arrhythmia Outcomes 52